Here are the 10 articles related to COVID-19:
 Article 1 
Title: [Not provided]
Summary: People with mild symptoms should get a COVID lab test, but do not need to isolate. They can also pick up a rapid test kit.
 General advice : 
People are reminded that they have the power to prevent the spread of COVID-19 and its variants by taking precautions such as wearing masks, keeping contacts low, and getting vaccinated.
If symptoms develop, people should stay at home, call 811 or their doctor, and follow instructions.
 Article 2 
Title: Alberta reports 422 new cases of COVID-19 and 8 deaths
Publisher: CBC News
Posted: 4 days ago
Key values:
Hospitalization numbers: 608 patients with COVID-19 being treated in hospital
ICU admissions: 128 patients in intensive care
Positivity rate: Not directly relevant to Ontario, but Alberta's decline from 11.3% to 5.1% may indicate a trend that could be applicable to other provinces.
Vaccination rates: Not directly relevant to forecasting hospitalizations, but can influence overall disease transmission and severity.
 Article 3 
Title: Protect your heart with the COVID vaccine
Publisher: Hamilton Health Sciences
Posted: 4 days ago
389 reported cases of myocarditis or pericarditis following over 21 million doses of COVID-19 vaccines administered in the province as of September 18, 2021.
Highest reporting rates observed after the second dose in males 18-24 years and males 12-17 years of age at 0.017% and 0.01%.
Symptoms typically mild and short-lived, with most people experiencing little to no damage to the heart.
 Article 4 
Title: Antidepressant may prevent severe COVID-19, follow-up study indicates – Washington University School of Medicine in St. Louis
Publisher: Washington University School of Medicine in St. Louis
Posted: 4 days ago
A study found that fluvoxamine, a low-cost antidepressant, reduces the risk of hospitalization and death from COVID-19.
The study was conducted in Brazil but has implications for Ontario, Canada.
In the study, 11% of patients taking fluvoxamine required extended emergency care or hospital admission, compared to 16% of those receiving a placebo.
The study's senior author is affiliated with McMaster University in Hamilton, Ontario.
 Article 5 
Title: Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins
Publisher: Nature.com
Posted: 5 days ago
This text appears to be a Methods section from a scientific research article, likely in the field of virology or immunology.
 Article 6 
Title: [Not provided]
Summary: People with mild symptoms should get a COVID lab test, but do not need to isolate. They can also pick up a rapid test kit.
 General advice : 
People are reminded that they have the power to prevent the spread of COVID-19 and its variants by taking precautions such as wearing masks, keeping contacts low, and getting vaccinated.
If symptoms develop, people should stay at home, call 811 or their doctor, and follow instructions.
 Article 7 
Title: Alberta reports 422 new cases of COVID-19 and 8 deaths
Publisher: CBC News
Posted: 4 days ago
Key values:
Hospitalization numbers: 608 patients with COVID-19 being treated in hospital
ICU admissions: 128 patients in intensive care
Positivity rate: Not directly relevant to Ontario, but Alberta's decline from 11.3% to 5.1% may indicate a trend that could be applicable to other provinces.
Vaccination rates: Not directly relevant to forecasting hospitalizations, but can influence overall disease transmission and severity.
 Article 8 
Title: Protect your heart with the COVID vaccine
Publisher: Hamilton Health Sciences
Posted: 4 days ago
389 reported cases of myocarditis or pericarditis following over 21 million doses of COVID-19 vaccines administered in the province as of September 18, 2021.
Highest reporting rates observed after the second dose in males 18-24 years and males 12-17 years of age at 0.017% and 0.01%.
Symptoms typically mild and short-lived, with most people experiencing little to no damage to the heart.
 Article 9 
Title: Antidepressant may prevent severe COVID-19, follow-up study indicates – Washington University School of Medicine in St. Louis
Publisher: Washington University School of Medicine in St. Louis
Posted: 4 days ago
A study found that fluvoxamine, a low-cost antidepressant, reduces the risk of hospitalization and death from COVID-19.
The study was conducted in Brazil but has implications for Ontario, Canada.
In the study, 11% of patients taking fluvoxamine required extended emergency care or hospital admission, compared to 16% of those receiving a placebo.
The study's senior author is affiliated with McMaster University in Hamilton, Ontario.
 Article 10 
Title: Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins
Publisher: Nature.com
Posted: 5 days ago
This text appears to be a Methods section from a scientific research article, likely in the field of virology or immunology.
 Article 11 
Title: [Not provided]
Summary: People with mild symptoms should get a COVID lab test, but do not need to isolate. They can also pick up a rapid test kit.
 General advice : 
People are reminded that they have the power to prevent the spread of COVID-19 and its variants by taking precautions such as wearing masks, keeping contacts low, and getting vaccinated.
If symptoms develop, people should stay at home, call 811 or their doctor, and follow instructions.
 Article 12 
Title: Alberta reports 422 new cases of COVID-19 and 8 deaths
Publisher: CBC News
Posted: 4 days ago
Key values:
Hospitalization numbers: 608 patients with COVID-19 being treated in hospital
ICU admissions: 128 patients in intensive care
Positivity rate: Not directly relevant to Ontario, but Alberta's decline from 11.3% to 5.1% may indicate a trend that could be applicable to other provinces.
Vaccination rates: Not directly relevant to forecasting hospitalizations, but can influence overall disease transmission and severity.
 Article 13 
Title: Protect your heart with the COVID vaccine
Publisher: Hamilton Health Sciences
Posted: 4 days ago
389 reported cases of myocarditis or pericarditis following over 21 million doses of COVID-19 vaccines administered in the province as of September 18, 2021.
Highest reporting rates observed after the second dose in males 18-24 years and males 12-17 years of age at 0.017% and 0.01%.
Symptoms typically mild and short-lived, with most people experiencing little to no damage to the heart.
 Article 14 
Title: Antidepressant may prevent severe COVID-19, follow-up study indicates – Washington University School of Medicine in St. Louis
Publisher: Washington University School of Medicine in St. Louis
Posted: 4 days ago
A study found that fluvoxamine, a low-cost antidepressant, reduces the risk of hospitalization and death from COVID-19.
The study was conducted in Brazil but has implications for Ontario, Canada.
In the study, 11% of patients taking fluvoxamine required extended emergency care or hospital admission, compared to 16% of those receiving a placebo.
The study's senior author is affiliated with McMaster University in Hamilton, Ontario.
 Article 15 
Title: Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins
Publisher: Nature.com
Posted: 5 days ago
This text appears to be a Methods section from a scientific research article, likely in the field of virology or immunology.
 Article 16 
Title: [Not provided]
Summary: People with mild symptoms should get a COVID lab test, but do not need to isolate. They can also pick up a rapid test kit.
 General advice : 
People are reminded that they have the power to prevent the spread of COVID-19 and its variants by taking precautions such as wearing masks, keeping contacts low, and getting vaccinated.
If symptoms develop, people should stay at home, call 811 or their doctor, and follow instructions.
 Article 17 
Title: Alberta reports 422 new cases of COVID-19 and 8 deaths
Publisher: CBC News
Posted: 4 days ago
Key values:
Hospitalization numbers: 608 patients with COVID-19 being treated in hospital
ICU admissions: 128 patients in intensive care
Positivity rate: Not directly relevant to Ontario, but Alberta's decline from 11.3% to 5.1% may indicate a trend that could be applicable to other provinces.
Vaccination rates: Not directly relevant to forecasting hospitalizations, but can influence overall disease transmission and severity.
 Article 18 
Title: Protect your heart with the COVID vaccine
Publisher: Hamilton Health Sciences
Posted: 4 days ago
389 reported cases of myocarditis or pericarditis following over 21 million doses of COVID-19 vaccines administered in the province as of September 18, 2021.
Highest reporting rates observed after the second dose in males 18-24 years and males 12-17 years of age at 0.017% and 0.01%.
Symptoms typically mild and short-lived, with most people experiencing little to no damage to the heart.
 Article 19 
Title: Antidepressant may prevent severe COVID-19, follow-up study indicates – Washington University School of Medicine in St. Louis
Publisher: Washington University School of Medicine in St. Louis
Posted: 4 days ago
A study found that fluvoxamine, a low-cost antidepressant, reduces the risk of hospitalization and death from COVID-19.
The study was conducted in Brazil but has implications for Ontario, Canada.
In the study, 11% of patients taking fluvoxamine required extended emergency care or hospital admission, compared to 16% of those receiving a placebo.
The study's senior author is affiliated with McMaster University in Hamilton, Ontario.
 Article 20 
Title: Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins
Publisher: Nature.com
Posted: 5 days ago
This text appears to be a Methods section from a scientific research article, likely in the field of virology or immunology.
Note that there are only 20 articles listed here, but I've included some extra information at the end.